To evaluate whether the negative action of RARα2 on myeloid differentiation is specific to APL and dependent on PML-RAR expression, we performed studies in the PML-RAR− and ATRA-sensitive HL-60 model [45, 46]. The gene discussed is RARA; the disease is acute promyelocytic leukemia.